Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Subclinical Macular Degeneration Requires Monitoring
Disease Discoveries

Subclinical Macular Degeneration Requires Monitoring

By Will DossJul 15, 2019
Share
Facebook Twitter Email
Amani Fawzi, MD, the Cyrus Tang and Lee Jampol Professor of Ophthalmology, was senior author of a study that affirmed the importance of monitoring patients with age-related macular degeneration.

A new Northwestern Medicine study has affirmed the importance of monitoring age-related macular degeneration to ensure the disease does not progress, and provided evidence that aspects of the early-stage disease may actually protect against later progression.

Amani Fawzi, MD, the Cyrus Tang and Lee Jampol Professor of Ophthalmology, was the senior author of the study published in journal PLOS One.

AMD is a common cause of irreversible vision loss, and early- and intermediate-stage AMD is diagnosed by the presence of drusen: yellow fatty lesions under the retina. These lesions are mostly harmless, and most patients are diagnosed at this stage and have little vision loss.

In contrast, later stage patients have newly formed blood vessels invading the retina, called choroidal neovascularization (CNV). These blood vessels can leak into the eye and cause rapid vision loss, but previous studies have found that if these blood vessels remain intact, they may in fact be beneficial, Fawzi said.

“The presence of these lesions, while concerning, can also theoretically be protective to the outer retina,” Fawzi said. “The underlying concept relates to the idea that these vascular lesions are adaptive, vascular channels, providing nourishment to the delicate outer retina, when the normal choriocapillaris fails.”

The mechanism that causes some vessels to leak — called exudative CNV — while others remain intact is unknown, but the new vessels are at not harmful until they start to leak. This means the current standard of care for patients with subclinical CNV is to simply monitor the condition, instead of treating patients with drugs that might slow blood vessel growth, according to Fawzi.

Until recently, diagnosing subclinical CNV was impossible without the use of invasive dye-based studies, but the advent of optical coherence tomography angiography (OCT angiography) has given doctors and clinicians the ability to identify subclinical CNV, Fawzi said.

“Before we had OCT angiography, which is quite convenient, rapid and non-invasive, we were stuck using invasive imaging with intravenous dyes, a test that could not be performed routinely in clinical care,” Fawzi said.

However, the literature on subclinical CNV remains sparse, and current estimates peg subclinical CNV rates among patients with AMD at between 6 and 27 percent.

In the current study, investigators studied 34 patients with AMD, each with one leaky eye and one eye with either intermediate AMD or intact, non-leaky CNV. Using OCT angiography modality to determine subclinical CNV, they followed up with patients after one year to see how many cases progressed to exudative CNV.

Of the five eyes with subclinical CNV, just one had developed exudative CNV after one year, according to the study, and none of the eyes without subclinical CNV had developed exudative CNV. While no specific measurements were predictive of conversion, these results are in line with previous work on the topic, and Fawzi believes monitoring patients with subclinical CNV is an effective way to detect the earliest signs of conversion and begin treatment only when the condition converts to exudative CNV.

“Once these lesions are identified in an eye, we insist on seeing the patient on a more stringent follow-up schedule, and we use the OCT angiography technology at each of these visits,” Fawzi said. “This heightened vigilance allows us to detect the exudative conversion, which occurs in about one-fifth of these eyes, a lot more readily.”

This work was supported by National Institutes of Health grant 1DP3DK108248.

Ophthalmology Patient Care Research
Share. Facebook Twitter Email

Related Posts

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

Comments are closed.

Latest News

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.